Jiang Zhong Pharmaceutical Co.,Ltd provided earning guidance for the quarter ended March 31, 2022. for the quarter, the company is expected to have a total operating income of approximately RMB 890 million, representing a year-on-year increase of approximately 30% and the net profit attributable to shareholders of the listed company is expected to be approximately RMB180 million, representing a year-on-year increase of approximately 11%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.48 CNY | -0.38% | +0.49% | +26.82% |
04-26 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-25 | Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.82% | 2.28B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.57% | 238B | |
+6.93% | 204B | |
-6.67% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- 600750 Stock
- News Jiang Zhong Pharmaceutical Co.,Ltd
- Jiang Zhong Pharmaceutical Co.,Ltd Provides Earning Guidance for the Quarter Ended March 31, 2022